CMC Biologics Completes First Stage of Expansion with Addition of Single-Use Facility
CMC biologics announced the completion of a new state-of-the-art disposable manufacturing facility at its Seattle, WA site. The addition comes as part of a staged major expansion plan, which will add significant production capacity to its existing facility to accommodate a growing demand for cGMP manufacture of biopharmaceuticals.
The multi-purpose, single-use facility will allow for early-phase clinical manufacture of a range of biopharmaceuticals, including monoclonal antibodies and other mammalian cell culture-based recombinant proteins. CMC Biologics has partnered with Hyclone to supply the new disposable facility with processing equipment, including a 100L and two 500L single-use bioreactors (SUBs) and disposable mixers.
"Disposable technology offers the advantages of increased flexibility and efficiency, decreased cross-contamination risks, and elimination of cleaning, sterilization and other change-over procedures typically associated with traditional steel tank facilities, while providing the same performance," said Andy Walker, Senior Director of Manufacturing. "Consequently, it provides a cost-effective strategy for reducing the speed to market for many biologics."
For other products where use of disposables is not feasible, CMC Biologics continues to offer its stainless-steel clinical and commercial cGMP manufacturing facility. They are currently increasing capacity with the addition of a second 3000L bioreactor train, identical to the existing line. Recent client demand has prompted initial steps in the plan toward build-out of a pre-existing structure anticipated to house two 5000L commercial-ready manufacturing lines. CMC Biologics has also increased headcount by more than 30% at its Seattle site to support the expansion.
Other news from the department manufacturing
These products might interest you
2mag Magnetic Stirrers Catalogue 2024 by 2mag
Wear-free magnetic stirrers for laboratory and cell culture
Request the 2mag catalogue 2024 with innovative stirring solutions now
YSTRAL Conti-TDS by ystral
YSTRAL Conti-TDS: The No. 1 in Powder Wetting
Induct, wet and disperse powder
Drive Units for Pro Mixer by Sartorius
Magnetic disposable agitator without surface contact perfect for biopharmaceutical process
Improved efficiency in cell harvesting and buffer preparation through advanced technology
Flexsafe® Bag for Pro Mixer without top port - 1500 L by Sartorius
Efficient bioprocess optimisation: 1500 L Flexsafe® Pro Mixer Bag
Improved mixing processes and easy handling thanks to ergonomic design and inline sensors
Innovative Magnetic Stirrers by 2mag
Magnetic stirrer of the future - for laboratories and pilot plants
Individually configurable, 100 % wear-free, 3-year guarantee
Most read news
More news from our other portals
See the theme worlds for related content
Topic world Antibodies
Antibodies are specialized molecules of our immune system that can specifically recognize and neutralize pathogens or foreign substances. Antibody research in biotech and pharma has recognized this natural defense potential and is working intensively to make it therapeutically useful. From monoclonal antibodies used against cancer or autoimmune diseases to antibody-drug conjugates that specifically transport drugs to disease cells - the possibilities are enormous
Topic world Antibodies
Antibodies are specialized molecules of our immune system that can specifically recognize and neutralize pathogens or foreign substances. Antibody research in biotech and pharma has recognized this natural defense potential and is working intensively to make it therapeutically useful. From monoclonal antibodies used against cancer or autoimmune diseases to antibody-drug conjugates that specifically transport drugs to disease cells - the possibilities are enormous